Skip to content
10-K/A

Annual Report

ASSURED PHARMACY, INC.

0001117768-14-000316

← back to feed
Filed
Apr 14, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Apr 2, 2014 10.48M sh
Capex FY 2013 · Dec 31, 2013 $54.84K
Capex FY 2013 · Dec 31, 2012 $21.29K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$1.88M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$530.82K
Cash And Equivalents FY 2013 · Dec 31, 2013 $2.86K
Cash And Equivalents FY 2013 · Dec 31, 2012 $21.3K
Cash And Equivalents FY 2013 · Dec 31, 2011 $23.32K
Stockholders Equity FY 2013 · Dec 31, 2013 −$10.47M
Stockholders Equity FY 2013 · Dec 31, 2012 −$6.49M
Stockholders Equity FY 2013 · Dec 31, 2011 −$3.33M
Current Liabilities FY 2013 · Dec 31, 2013 $2.58M
Current Liabilities FY 2013 · Dec 31, 2012 $7.57M
Total Liabilities FY 2013 · Dec 31, 2013 $9M
Total Liabilities FY 2013 · Dec 31, 2012 $8.71M
Current Assets FY 2013 · Dec 31, 2013 $830.28K
Current Assets FY 2013 · Dec 31, 2012 $1.26M
Total Assets FY 2013 · Dec 31, 2013 $1.05M
Total Assets FY 2013 · Dec 31, 2012 $2.22M
Sga Expense FY 2013 · Dec 31, 2013 $2.13M
Sga Expense restated FY 2013 · Dec 31, 2012 $2.27M
Net Income FY 2013 · Dec 31, 2013 −$3.36M
Net Income FY 2013 · Dec 31, 2012 −$4.01M
Gross Profit FY 2013 · Dec 31, 2013 $1.12M
Gross Profit restated FY 2013 · Dec 31, 2012 $1.33M
Cost Of Revenue FY 2013 · Dec 31, 2013 $4.07M
Cost Of Revenue restated FY 2013 · Dec 31, 2012 $4.31M
Revenue FY 2013 · Dec 31, 2013 $5.19M
Revenue restated FY 2013 · Dec 31, 2012 $5.64M